Key features and details | |
Cat. No. | MABL-3129 |
Name | Anti-trans-sialidase mAbs |
Clone No. | AFD- 13G9 |
From | Recombinant Antibody |
Isotype | Engineer antibody |
Application | crystallization, neutralize, IF |
Species Reactivity | Trypanosoma cruzi |
Basic Information | |
Specificity | 13G9 is a neutralizing antibody which binds specifically and with high affinity (KD ~0.72 nM) to a conformational epitope on the Trypanosoma cruzi TS protein – the antibody binds to TS in such a way as to prevent the movement of Y119, whose mobility has a key role in the trans-glycosidase mechanism. Specificity of binding was deduced by the absence of reactivity against TS from the closely related Trypanosoma rangeli and Trypanosoma brucei. A Fab fragment of the antibody was generated by digestion with papain - the Fab fragment possesses lower inhibitory activity against T. cruzi TS (Fab IC50 ~1.6nM; full- length mAb IC50 ~56pM). |
Alternative Name | TS |
UniProt | Q26966 |
Immunogen | 13G9 was prepared by immnuizing mice with recombinant TS (Δ1443TS), which is fully active but includes a deletion of a non-neutralizing epitope (speeds up production of neutralizing antibodies). The antibody was selected for by screening using a TS-inhibition assay. |
Application Notes | 13G9 can be used for IF with whole parasites which allows membrane localization of TS to be observed. The antibody can inhibit TS-mediated sialylation of the parasite via the transfer of sialic acid from the enivronment to the surface of the parasite. Cell invasion (a process in which TS plays a key role) is also inhibited by 13G9 and was shown to greatly reduce the number of T. cruzi-infected cells. Passive transfer of 13G9 to T. cruzi-infected mice provided protection against the delterious effects that TS has on the immune system and platelets. The 13G9 Fab fragment was also used to crystallize TS for structure studies and this allowed the binding to TS to be seen. |
Antibody First Published | Buschiazzo et al. Trypanosoma cruzi trans-sialidase in complex with a neutralizing antibody: structure/function studies towards the rational design of inhibitors. PLoS Pathog. 2012 Jan;8(1):e1002474. PMID:22241998 |
Note on publication | Describes the production of 13G9 and functional and structural studies on th mAb. |
COA Information （For reference only, actual COA shall prevail） | |
Size | 100 μg Purified antibody. |
Concentration | 1 mg/ml. |
Purification | Protein A affinity purified |
Buffer | PBS with 0.02% Proclin 300. |
Concentration | 1 mg/ml. |
Storage Recommendation | Store at 4⁰C for up to 3 months. For longer storage, aliquot and store at - 20⁰C. |
